The recent announcement of the resurrection of the dire wolf generated considerable global media attention and widespread ...

The Wasatch Ultra Growth Fund—Investor Class underperformed the benchmark with a return of -14.81%. Read more here.

Not since DDT was introduced to U.S. agriculture to kill insects after World War Two has a farm chemical been as important to ...

Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions ...

negative allosteric modulators (NAMs) demonstrated robust, dose-dependent antiseizure efficacy across a broad array of focal ...

Viking Therapeutics offers leaner operations, lower complexity, faster trial execution, and less execution risk. Learn more ...

BNC210 has demonstrated rapid-onset, broad and meaningful anti-anxiety effects in completed clinical trials in panic attacks, ...

SAN FRANCISCO, (GLOBE NEWSWIRE) --  23andMe Holding Co. (“23andMe” or the “Company”) (OTC: MEHCQ), a leading human genetics and biotechnology company, today announced that it has entered into a ...

Randee’s cancer had metastasized. When her doctor tested her for the PIK3CA gene mutation, she was able to make informed ...

Phase 3 clinical trial of BNC-210 in social anxiety disorder on track for topline readout in Q3 2025a7 nicotinic acetylcholine receptor PAM MK-1167 partnered with Merck ...